Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
The World Health Organization has suspended testing the intestinal sickness tranquilize hydroxychloroquine in COVID-19 patients because of security concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Hydroxycholoroquine has been touted by Donald Trump and others as a potential treatment for the ailment brought about by the novel coronavirus. The U.S. President has said he was taking the medication to help forestall disease.
“The official gathering has actualized an impermanent respite of the hydroxychloroquine arm inside the Solidarity preliminary while the wellbeing information is inspected by the information security checking board,” Tedros told a web based instructions.
He said different arms of the preliminary – a significant universal activity to hold clinical trial of potential medicines for the infection – were proceeding. The WHO has recently prescribed against utilizing hydroxychloroquine to treat or forestall coronavirus contaminations, with the exception of as a feature of clinical preliminaries.
Dr. Mike Ryan, leader of the WHO crises program, said the choice to suspend preliminaries of hydroxychloroquine had been removed from “a wealth of alert”.
